The UK Wound Dressings Market was valued at $326.6 Million in 2025 and projected to reach to $460.2 Million by 2030, representing a compound annual growth rate of 7.1%. The UK wound dressings market is positioned for sustained growth through 2030, driven by demographic shifts and healthcare modernization.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
The UK wound dressings market is valued at £326.6 million in 2025 and is projected to reach £460.2 million by 2030, demonstrating strong growth potential in the healthcare sector.
The UK's aging demographic is a primary growth catalyst, with an increasing elderly population requiring advanced wound care management and chronic wound treatment solutions.
The UK's robust National Health Service infrastructure and commitment to evidence-based medicine create a favorable environment for adoption of innovative wound dressing technologies.
Rising prevalence of chronic wounds, including diabetic ulcers and pressure injuries, combined with increased healthcare spending, is driving demand for advanced wound care solutions across UK healthcare facilities.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | ADVANCED WOUND DRESSINGS (Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 6.5% from 2025 to 2030 |
| Largest Segment | ADVANCED WOUND DRESSINGS (Type) |
| Market Size Base Year (Billions) | ~USD 11.58 (2025) |
| Revenue Forecast (Billions) | ~USD 15.87 (2030) |
| Segments Covered | Type, Wound Type |
2 segment dimensions are covered across the global market.
| Segment | 2023 | 2024 | 2025 | 2026 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|
| HOME CARE SETTINGS | 150.7 | 159.7 | 169.5 | 180.4 | 205.1 | 219.4 | 236.3 | 6.9 |
| HOSPITALS, ASCS, AND CLINICS | 216.9 | 226.6 | 237.3 | 248.8 | 274.9 | 289.6 | 307.3 | 5.3 |
| OTHER END USERS | 89.9 | 93.3 | 97 | 101 | 110 | 115.1 | 121.4 | 4.6 |
| TOTAL | 457.5 | 479.6 | 503.8 | 530.1 | 590 | 624.1 | 665 | 5.7 |
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| NITTO DENKO CORPORATION | Japan | Public Company | Adhesive tapes and surface protection films,Electronics and display materials (FPD, touch panel, FPC, semiconductor process),Fluoroplastic and porous films (NITOFLON, TEMISH, breathable materials), |
| SOLVENTUM | United States | Public Company | Medsurg,Dental Solutions,Health Information Systems, |
| MöLNLYCKE AB | Sweden | Private Company | Wound Care,Operating Room Solutions,Gloves, |
| CARDINAL HEALTH | United States | Public Company | Branded pharmaceutical distribution,Generic and OTC pharmaceutical distribution,Specialty pharmaceutical and manufacturer services, |
| SMITH+NEPHEW | United Kingdom | Public Company | Orthopaedics (hip, knee, trauma, extremities, other reconstruction),Sports Medicine & ENT (joint repair, arthroscopic enabling technologies, ENT solutions),Advanced Wound Management (advanced wound care, bioactives, devices), |
| CONVATEC GROUP PLC | United Kingdom | Public Company | Ostomy Care,Advanced Wound Care,Continence Care, |
| PAUL HARTMANN AG | Germany | Public Company | Wound Care,Incontinence Management,Infection Management, |
| OWENS & MINOR | United States | Public Company | In-home diabetes care and supply delivery,Home respiratory therapy (oxygen and non-invasive ventilation),Obstructive sleep apnea (CPAP/BiPAP and support services), |
| INTEGRA LIFESCIENCES CORPORATION | United States | Public Company | Codman Specialty Surgical (neurosurgery and neurocritical care),Tissue Technologies – wound and burn care,Tissue Technologies – surgical reconstruction and nerve/tendon repair, |
| ESSITY AKTIEBOLAG | Sweden | Public Company | Health & Medical,Consumer Goods,Professional Hygiene, |
| ADVANCED MEDICAL SOLUTIONS GROUP PLC | United Kingdom | Public Company | Surgical products (tissue adhesives, haemostats, biosurgical, fixation, sealants, infection control),Branded woundcare dressings (ActivHeal),White-label/OEM woundcare dressings, |
| MATIV HOLDINGS, INC. | United States | Public Company | Filtration & Advanced Materials,Tapes, Labels, and Liners,Paper and Packaging Products, |
Nitto Denko Corporation is a Japanese public company founded in 1918 with 26,477 employees. The company operates as a diversified manufacturer serving global markets.
Solventum is a public American company founded in 2023 with 20,584 employees. The company operates in the healthcare and industrial sectors.
Mölnlycke AB is a private Swedish company founded in 1849 with 8,463 employees. The company operates in the healthcare and medical products industry.
Cardinal Health is a public American company founded in 1979 with 55,392 employees. The company is a major distributor of pharmaceuticals and medical products.
Smith+Nephew is a public British company founded in 1856 with 16,988 employees. The company specializes in medical devices and healthcare solutions.
ConvaTec Group PLC is a public British company founded in 1978 with 10,910 employees. The company manufactures and distributes medical products and devices.
Paul Hartmann AG is a public German company founded in 1818 with 10,066 employees. The company produces medical and hygiene products.
Owens & Minor is a public American company founded in 1882 with 6,500 employees. The company distributes medical and surgical supplies.
Integra LifeSciences Corporation is a public American company founded in 1989 with 4,427 employees. The company develops and manufactures medical devices and regenerative technologies.
Essity Aktiebolag is a public Swedish company founded in 1849 with 36,000 employees. The company manufactures hygiene and health products.
Advanced Medical Solutions Group PLC is a public British company founded in 1991 with 1,800 employees. The company develops and manufactures advanced wound care and surgical products.
Mativ Holdings, Inc. is a public American company founded in 1995 with 5,000 employees. The company manufactures specialty materials and engineered products.
The UK wound dressings market is valued at £326.6 million in 2025 and is expected to grow to £460.2 million by 2030.
The UK wound dressings market is projected to grow at a compound annual growth rate (CAGR) of 7.1% from 2025 to 2030.
The UK market is driven by an aging population, increased prevalence of chronic wounds, NHS investment in advanced wound care, and growing adoption of innovative dressing technologies.
The UK market shows strong demand for hydrogels, foam dressings, antimicrobial dressings, and advanced formulations designed for diabetic ulcers and pressure injuries.
The UK wound dressings market, with a 7.1% CAGR, demonstrates robust growth supported by NHS infrastructure, regulatory frameworks, and high healthcare spending on wound care solutions.
The study involved major activities in estimating the current market size for the wound dressings market. Exhaustive secondary research was done to collect information on the wound care industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the wound dressings market.
The four steps involved in estimating the market size are:
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), , Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global wound dressings market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends, to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the wound dressings market. The primary sources from the demand side include hospitals and surgical centers, home healthcare settings, long-term care/nursing homes and research institutions and universities. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.
The following is a breakdown of the primary respondents:
Note 1: Other designations include sales managers, marketing managers, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.
To know about the assumptions considered for the study, download the pdf brochure
For the global market value, annual revenues were calculated based on the revenue mapping of major wound dressings manufacturers and OEMs active in the global wound dressings market. All the major service providers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. The global wound dressings market was split into various segments and sub-segments based on:
The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.
The research methodology used to estimate the market size includes the following:

After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
A wound refers to an injury involving the dissection or rupture of tissues or membranes, typically caused by external trauma or involuntary actions. To ensure proper healing and protect the wound from further harm or infection.
Wound dressings serve a critical role in maintaining a protective barrier, supporting healing, managing exudate (fluid discharge), and preventing infection or complications. They are widely used by surgeons, physicians, caregivers, and patients to facilitate healing in a controlled and hygienic environment.
Wound dressings are available in various types, generally categorized into traditional wound dressings (such as gauze and bandages) and advanced wound dressings (including hydrocolloids, foams, alginates, and hydrogel dressings). The choice of dressing depends on the wound’s characteristics—its type, size, location, depth, and level of exudate.
Full forecast, segment splits, and company analysis for all Wound Dressings Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report